Larissa Maier, PhD

Title(s)Postdoc Scholar - Employee, Clinical Pharmacy
SchoolSchool of Pharmacy
ORCID ORCID Icon0000-0002-4302-0488 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UNODC, ViennaConsultancy12/2017Drug Use Epidemiology
    University of Zurich, ZurichPh.D.03/2017Addiction Research
    King's College London, LondonFellowship09/2014Addiction Research
    University of Zurich, ZurichM.Sc.07/2012Clinical Psychology
    University of Zurich, ZurichB.Sc. 07/2010Psychology
    Collapse Awards and Honors
    National Institute on Drug Abuse (NIDA)2020  - 2021NIDA INVEST Fellowship, San Francisco
    Swiss National Science Foundation (SNSF)2018  - 2019Early Postdoc Mobility Fellowship, San Francisco
    College on Problems of Drug Dependence (CPDD)2018Travel Award for Early Career Investigators for the CPDD 80th Annual Scientific Meeting, San Diego
    National Institute on Drug Abuse (NIDA) 2018Travel Award for the SPR 26th Annual Meeting, Washington D.C.
    University of Zurich (UZH)2017Graduate Campus Grant for a 2-Day Workshop on Gender Equality & Early Career Development, Zurich
    Training With Stakeholders – Applying EU Drug and Addiction Research (TWIST)2017Early Career Bursary for the 2nd Addictions, Lisbon
    International Society for the Study of Drug Policy (ISSDP) 2017  - `Travel Award for the 11th ISSDP conference, Aarhus
    German Society for Addiction Medicine (DGS) 20161st Place Short Talks, Berlin
    European Society of Prevention Research (EUSPR)2016Early Career Bursary for the 7th EUSPR Conference, Berlin
    Swiss Academy of Humanities and Social Sciences (SAGW)2015Travel Award for the 9th Club Health Conference, Lisbon
    Swiss Society of Addiction Medicine (SSAM)20151st Place Poster Award, Berne
    University of Zurich (UZH)2014Travel Award for a Research Stay at King’s College London
    Swiss Academy of Humanities and Social Sciences (SAGW)2013Travel Award for the 6th EUPHA Conference, Bruxelles

    Collapse Overview 
    Collapse Overview
    Dr. Larissa J. Maier works with Dr. Dorie Apollonio at the UCSF Department of Clinical Pharmacy. Prior to this, she worked with Dr. Danielle Ramo and Dr. Derek Satre at the UCSF Department of Psychiatry and Biobehavioral Sciences. She earned her BSc, MSc, and PhD from the University of Zurich. Before joining UCSF, Dr. Maier worked at the Swiss Research Institute for Public Health and Addiction (ISGF) in Zurich and at the United Nations Office on Drugs and Crime (UNODC) in Vienna.

    Dr. Maier is a member of the Core Research Team of Global Drug Survey (GDS) aiming to make drug use safer, regardless of the legal status of the drug. At UCSF, she leads the Science Policy Group (SPG) and the Psychedelic and Entheogen Academic Council (PEAC). She is a member of the U.S. National Science Policy Network (NSPN) passionate about connecting people and ideas. In addition, she serves on several committees to facilitate international relations, diversity, communication, and early career networking at the College on Problems of Drug Dependence (CPDD), the European Society for Prevention Research (EUSPR), the International AIDS Society (IAS), the International Society of Substance Use Professionals (ISSUP), the International Society for the Study of Drug Policy (ISSDP), the Society for Prevention Research (SPR), the Society of Addiction Psychology (APA Division 50), and the United Nations Associations of the USA San Francisco Chapter (UNA-SF).
    Collapse In The News

    Collapse Research 
    Collapse Research Activities and Funding
    Impact of local strategies to prevent opioid-related overdose deaths
    National Institute on Drug Abuse (NIDA) Sep 8, 2020 - Sep 7, 2021
    Role Description: NIDA INVEST Fellowship
    Youth substance use - efficacy of social media interventions to reduce use and impact of state-level drug policies
    Swiss National Science Foundation (SNSF) P2ZHP1_174812Apr 1, 2018 - Sep 30, 2019
    Role Description: Early Postdoc Mobility Fellowship

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis. Psychopharmacology (Berl). 2021 Sep 17. Craft S, Ferris JA, Barratt MJ, Maier LJ, Lynskey MT, Winstock AR, Freeman TP. PMID: 34533608.
      View in: PubMed   Mentions:    Fields:    
    2. Where and What You Drink Is Linked to How Much You Drink: An Exploratory Survey of Alcohol Use in 17 Countries. Subst Use Misuse. 2021 Aug 11; 1-10. Davies EL, Cooke R, Maier LJ, Winstock AR, Ferris JA. PMID: 34378484.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Comparing Transgender and Cisgender Experiences of Being Taken Advantage of Sexually While Under the Influence of Alcohol and/or Other Drugs. J Sex Res. 2021 Apr 28; 1-6. Connolly D, Aldridge A, Davies E, Maier LJ, Ferris J, Gilchrist G, Winstock A. PMID: 33908334.
      View in: PubMed   Mentions:    Fields:    
    4. A Facebook intervention to address cigarette smoking and heavy episodic drinking: A pilot randomized controlled trial. J Subst Abuse Treat. 2021 03; 122:108211. Meacham MC, Ramo DE, Prochaska JJ, Maier LJ, Delucchi KL, Kaur M, Satre DD. PMID: 33509414.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    5. Patterns of methamphetamine production among an international sample of methamphetamine 'cooks'. Drug Alcohol Rev. 2020 Nov 10. Puljevic C, Zahnow R, Benfer I, Winstock AR, Maier LJ, Barratt MJ, Ferris J. PMID: 33170968.
      View in: PubMed   Mentions:    Fields:    
    6. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. J Psychopharmacol. 2020 Oct 08; 269881120953994. Petranker R, Anderson T, Maier LJ, Barratt MJ, Ferris JA, Winstock AR. PMID: 33591231.
      View in: PubMed   Mentions: 1     Fields:    
    7. Drinking to excess and the tipping point: An international study of alcohol intoxication in 61,000 people. Int J Drug Policy. 2020 09; 83:102867. Davies EL, Cooke R, Maier LJ, Winstock AR, Ferris JA. PMID: 32707478.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Factors associated with readiness to quit smoking among young adults enrolled in a Facebook-based tobacco and alcohol intervention study. Addict Behav. 2020 12; 111:106524. Maier LJ, Ramo DE, Kaur M, Meacham MC, Satre DD. PMID: 32791434.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    9. Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada. Int J Drug Policy. 2021 05; 91:102789. Winstock AR, Lynskey MT, Maier LJ, Ferris JA, Davies EL. PMID: 32499118.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    10. Comparing intentions to reduce substance use and willingness to seek help among transgender and cisgender participants from the Global Drug Survey. J Subst Abuse Treat. 2020 05; 112:86-91. Connolly D, Davies E, Lynskey M, Barratt MJ, Maier L, Ferris J, Winstock A, Gilchrist G. PMID: 32199550.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Intention to reduce drinking alcohol and preferred sources of support: An international cross-sectional study. J Subst Abuse Treat. 2019 04; 99:80-87. Davies EL, Maier LJ, Winstock AR, Ferris JA. PMID: 30797399.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. Pharmacological cognitive enhancement among non-ADHD individuals-A cross-sectional study in 15 countries. Int J Drug Policy. 2018 08; 58:104-112. Maier LJ, Ferris JA, Winstock AR. PMID: 29902691.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    13. Changing the conversation to make drug use safer. Lancet. 2018 05 19; 391(10134):1965. The Lancet . PMID: 29864007.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Are ecstasy induced serotonergic alterations overestimated for the majority of users? J Psychopharmacol. 2018 07; 32(7):741-748. Szigeti B, Winstock AR, Erritzoe D, Maier LJ. PMID: 29733742.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries. Int J Drug Policy. 2018 06; 56:162-175. Benfer I, Zahnow R, Barratt MJ, Maier L, Winstock A, Ferris J. PMID: 29731288.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    16. Drug-related police encounters across the globe: How do they compare? Int J Drug Policy. 2018 06; 56:197-207. Hughes CE, Barratt MJ, Ferris JA, Maier LJ, Winstock AR. PMID: 29699837.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    17. Do people with intersecting identities report more high-risk alcohol use and lifetime substance use? Int J Public Health. 2018 Jun; 63(5):621-630. Demant D, Oviedo-Trespalacios O, Carroll JA, Ferris JA, Maier L, Barratt MJ, Winstock AR. PMID: 29605878.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    18. Injecting drug use: Gendered risk. Int J Drug Policy. 2018 06; 56:81-91. Zahnow R, Winstock AR, Maier LJ, Levy J, Ferris J. PMID: 29614392.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Moving on From Representativeness: Testing the Utility of the Global Drug Survey. Subst Abuse. 2017; 11:1178221817716391. Barratt MJ, Ferris JA, Zahnow R, Palamar JJ, Maier LJ, Winstock AR. PMID: 28924351.
      View in: PubMed   Mentions:
    20. Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile. Hum Psychopharmacol. 2017 05; 32(3). Coney LD, Maier LJ, Ferris JA, Winstock AR, Barratt MJ. PMID: 28517366.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Efficacy of an internet-based self-help intervention to reduce co-occurring alcohol misuse and depression symptoms in adults: study protocol of a three-arm randomised controlled trial. BMJ Open. 2016 05 25; 6(5):e011457. Schaub MP, Blankers M, Lehr D, Boss L, Riper H, Dekker J, Goudriaan AE, Maier LJ, Haug S, Amann M, Dey M, Wenger A, Ebert DD. PMID: 27225652.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    22. Author's response on Arria (2016): Intention matters--using the terminology 'pharmacological neuroenhancement' as a behavioural definition based on the assumed functionality. Addiction. 2016 May; 111(5):938-9. Maier LJ, Haug S, Schaub MP. PMID: 26956687.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Swiss University Students' Attitudes toward Pharmacological Cognitive Enhancement. PLoS One. 2015; 10(12):e0144402. Maier LJ, Liakoni E, Schildmann J, Schaub MP, Liechti ME. PMID: 26657300.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. The Use of Prescription Drugs, Recreational Drugs, and "Soft Enhancers" for Cognitive Enhancement among Swiss Secondary School Students. PLoS One. 2015; 10(10):e0141289. Liakoni E, Schaub MP, Maier LJ, Glauser GV, Liechti ME. PMID: 26505633.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    25. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students. Drug Alcohol Depend. 2015 Nov 01; 156:221-227. Maier LJ, Haug S, Schaub MP. PMID: 26455555.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Erratum to: Evaluating the efficacy of a web-based self-help intervention with and without chat counseling in reducing the cocaine use of problematic cocaine users: the study protocol of a pragmatic three-arm randomized controlled trial. BMC Psychiatry. 2015 Sep 16; 15:218. Schaub MP, Maier LJ, Wenger A, Stark L, Berg O, Beck T, Quednow BB, Haug S. PMID: 26376748.
      View in: PubMed   Mentions:    Fields:    
    27. Prevalence of and motives for pharmacological neuroenhancement in Switzerland--results from a national Internet panel. Addiction. 2016 Feb; 111(2):280-95. Maier LJ, Haug S, Schaub MP. PMID: 26189457.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Evaluating the efficacy of a web-based self-help intervention with and without chat counseling in reducing the cocaine use of problematic cocaine users: the study protocol of a pragmatic three-arm randomized controlled trial. BMC Psychiatry. 2015 Jul 10; 15:156. Schaub MP, Maier LJ, Wenger A, Stark L, Berg O, Beck T, Quednow BB, Haug S. PMID: 26159624.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality? PLoS One. 2015; 10(6):e0129805. Maier LJ, Wunderli MD, Vonmoos M, Römmelt AT, Baumgartner MR, Seifritz E, Schaub MP, Quednow BB. PMID: 26107846.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    30. To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS One. 2013; 8(11):e77967. Maier LJ, Liechti ME, Herzig F, Schaub MP. PMID: 24236008.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    Larissa's Networks
    Concepts (141)
    Derived automatically from this person's publications.
    Co-Authors (4)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department